These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16509530)

  • 1. A daily comprehensive muscle training programme increases lean mass and spontaneous activity in children with Prader-Willi syndrome after 6 months.
    Schlumpf M; Eiholzer U; Gygax M; Schmid S; van der Sluis I; l'Allemand D
    J Pediatr Endocrinol Metab; 2006 Jan; 19(1):65-74. PubMed ID: 16509530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.
    Myers SE; Whitman BY; Carrel AL; Moerchen V; Bekx MT; Allen DB
    Am J Med Genet A; 2007 Mar; 143A(5):443-8. PubMed ID: 17103437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving body composition and physical activity in Prader-Willi Syndrome.
    Eiholzer U; Nordmann Y; l'Allemand D; Schlumpf M; Schmid S; Kromeyer-Hauschild K
    J Pediatr; 2003 Jan; 142(1):73-8. PubMed ID: 12520259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prader-Willi syndrome: how does growth hormone affect body composition and physical function?
    Carrel AL; Allen DB
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1445-51. PubMed ID: 11837498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everyday physical activity and adiposity in Prader-Willi syndrome.
    van den Berg-Emons R; Festen D; Hokken-Koelega A; Bussmann J; Stam H
    J Pediatr Endocrinol Metab; 2008 Nov; 21(11):1041-8. PubMed ID: 19189698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peculiar body composition in patients with Prader-Labhart-Willi syndrome.
    Brambilla P; Bosio L; Manzoni P; Pietrobelli A; Beccaria L; Chiumello G
    Am J Clin Nutr; 1997 May; 65(5):1369-74. PubMed ID: 9129464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.
    Whitman B; Carrel A; Bekx T; Weber C; Allen D; Myers S
    J Pediatr Endocrinol Metab; 2004 Apr; 17(4):591-600. PubMed ID: 15198290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment.
    Eiholzer U; Meinhardt U; Gallo C; Schlumpf M; Rousson V; l'Allemand D
    J Pediatr; 2009 Feb; 154(2):225-9. PubMed ID: 18822426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early manifestations of Prader-Willi syndrome: influence of growth hormone.
    Eiholzer U; Schlumpf M; Nordmann Y; l'Allemand D
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1441-4. PubMed ID: 11837497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance.
    Eiholzer U; Gisin R; Weinmann C; Kriemler S; Steinert H; Torresani T; Zachmann M; Prader A
    Eur J Pediatr; 1998 May; 157(5):368-77. PubMed ID: 9625332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lean Body Mass in Boys With Prader-Willi Syndrome Increases Normally During Spontaneous and Induced Puberty.
    Noordam C; Stephan A; Eiholzer U
    J Clin Endocrinol Metab; 2023 Aug; 108(9):2299-2306. PubMed ID: 36869831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome.
    McAlister KL; Fisher KL; Dumont-Driscoll MC; Rubin DA
    J Pediatr Endocrinol Metab; 2018 Aug; 31(8):837-845. PubMed ID: 29975666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerometer-determined physical activity and walking capacity in persons with Down syndrome, Williams syndrome and Prader-Willi syndrome.
    Nordstrøm M; Hansen BH; Paus B; Kolset SO
    Res Dev Disabil; 2013 Dec; 34(12):4395-403. PubMed ID: 24139709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.